Saturday, May 11 2024
11:15 AM – 11:30 AM ET - Ballroom 4
391: An Evolved AAV Variant Enables In Vivo CAR-T Cell Generation, Tumor Cytotoxicity, and B Cell Elimination
Lijia Ma
Westlake University
Disclosures: L. Ma: 1; Commercial Interest i.e. Company X; Westlake Genetech. 1; What was received? i.e. Honorarium; Stock. 1; For what role? i.e. Speaker; Scientific founder and board member.
Related Abstract